kenya: kenyan court ruling upholds access to generic drugs

CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update KENYA: Kenyan Court Ruling Upholds Access to Generic Drugs
April 23, 2012

Reuters (04.20.12) - Monday, April 23, 2012 High Court Judge Mumbi Ngugi ruled Friday that lawmakers must revisit Kenya's Anti-Counterfeit Bill of 2008 to more clearly define the difference between generic and fake medicines. A previous court order had prevented the act from taking effect. Three HIV patients filed suit in 2009, claiming the act was unconstitutional because it threatened the importation of life-saving medicines by confusing generics and fakes. Generic drugs comprise the majority of medicines used in Kenya. Slightly more than 500,000 of the 1.5 million Kenyans living with HIV/AIDS have access to antiretroviral drugs, most of which are generics. "The act is vague and could undermine access to affordable generic medicines since the act had failed to clearly distinguish between counterfeit and generic medicines," Ngugi said. In a statement issued by Doctors Without Borders, petitioner Patricia Asero said the ruling "speaks against any ambiguity that serves to undermine access to generic medicines and puts the lives of people before profit."

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 Tentative approval of lamivudine and tenofovir disoproxil fumarate Tablets, 300 mg/300 mg Too many patients, too little time After a decade, global AIDS program looks ahead South Africa: Mandela name pulled into politics General Secretariat of the League of Arab States and UNAIDS to work toward an accelerated HIV response in the Arab Region HarborPath Receives $250,000 Elton John AIDS Foundation Grant to Support Program Expansion CANADA: Health Officials in St. John's N.L., Inform 50 People of Tuberculosis Risk OHIO: Cleveland LGBT Community Center Offers Free Support Groups and HIV, STD Testing: The Frugal Patient CALIFORNIA: Local Church Sends HIV/AIDS Care Packs to Swaziland NEVADA: Clinics Offer Low-Cost Care for those Lacking Insurance KENYA: Kenya Launches Universal HPV Vaccine Access to Youths Initiation rules help to keep young men safe and healthy NEW JERSEY: Drug Company Donates Thousands to HIV/AIDS Orgs NORTH KOREA: North Korea Sees Surge of Drug-Resistant Tuberculosis Experimental Gilead drug effective in early-stage leukemia trial Public Meeting on HIV Patient-Focused Drug Development and HIV Cure Research: June 14, 2013 India's Largest Generic Drugmaker Ranbaxy Pays $500 Million to Settle Systemic Generic Drug Manufacturing Fraud AHF Shareholder Advocates Challenge Gilead on Drug Pricing at AGM 2012 US medicine sales show shifts by drug type Mass. panel approves rules for medical marijuana
Copyright © 2012 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles. Information in this article was accurate in April 23, 2012. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.